Thrombolysis in patients with pulmonary embolism and elevated heart-type fatty acid-binding protein levels

Journal of Thrombosis and Thrombolysis

Volumn 37, Issue 4, 2014, Pages 483-489

  Gul, Enes Elvin ^a,b   Can, Ilknur ^a   Kayrak, Mehmet ^a   Abdulhalikov, Turyan ^a   Erdogan, Halil Ibrahim ^a   Altunbas, Gokhan ^a   Ozdemir, Kurtulus ^a   Gok, Hasan ^a  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^b Malkara State Hospital   (Turkey)

Author keywords

Acute pulmonary embolism; h FABP; Thrombolysis; Treatment

Indexed keywords

ALTEPLASE; FATTY ACID BINDING PROTEIN; INOTROPIC AGENT; STREPTOKINASE; FABP3 PROTEIN, HUMAN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DETERIORATION; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART RIGHT VENTRICLE OVERLOAD; HIGH RISK PATIENT; HUMAN; LOADING DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; AGED; BLOOD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; MIDDLE AGED; PULMONARY EMBOLISM; RISK FACTOR; SURVIVAL RATE;

AGED; DISEASE-FREE SURVIVAL; FATTY ACID-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM; RISK FACTORS; SURVIVAL RATE; THROMBOLYTIC THERAPY;

EID: 84899689399     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-013-1008-7     Document Type: Article

References (24)

1. Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galie N, Pruszczyk P et al (2008) Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 29(18):2276-2315
2. Konstantinides S, Geibel A, Olschewski M, Kasper W, Hruska N, Jackle S et al (2002) Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106(10):1263-1268 (Pubitemid 34988646)
3. Storch J, Thumser AE (2000) The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 1486(1):28-44 (Pubitemid 30336790)
4. Alhadi HA, Fox KA (2004) Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid-binding protein. QJM 97(4):187-198 (Pubitemid 38489158)
5. Seino Y, Tomita Y, Takano T, Ohbayashi K (2004) Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests. Circ J 68(2):144-148 (Pubitemid 38197252)
6. Kaczynska A, Pelsers MM, Bochowicz A, Kostrubiec M, Glatz JF, Pruszczyk P (2006) Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta 371(1-2):117-123 (Pubitemid 44162903)
7. Nakata T, Hashimoto A, Hase M, Tsuchihashi K, Shimamoto K (2003) Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 99(2):96-104 (Pubitemid 36506388)
8. Dellas C, Puls M, Lankeit M, Schafer K, Cuny M, Berner M et al (2010) Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J Am Coll Cardiol 55(19):2150-2157
9. Boscheri A, Wunderlich C, Langer M, Schoen S, Wiedemann B, Stolte D et al (2010) Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk. Am Heart J 160(2):294-300
10. Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347(15):1143-1150
11. Agnelli G, Becattini C, Kirschstein T (2002) Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis. Arch Intern Med 162(22):2537-2541 (Pubitemid 35453492)
12. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al (1989) Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2(5):358-367
13. Puls M, Dellas C, Lankeit M, Olschewski M, Binder L, Geibel A et al (2007) Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J 28(2):224-229
14. Niizeki T, Takeishi Y, Takabatake N, Shibata Y, Konta T, Kato T et al (2007) Circulating levels of heart-type fatty acid-binding protein in a general Japanese population: effects of age, gender, and physiologic characteristics. Circ J 71(9):1452-1457 (Pubitemid 47378449)
15. http://accscientificsession.cardiosource.org/en/Home/News-Media/ Media-Center/News-Releases/2013/03/PEITHO.aspx
16. Sharifi M, Bay C, Skrocki L, Rahimi F, Mehdipour M (2013) Moderate pulmonary embolism treated with thrombolysis (from the "MOPETT" Trial). Am J Cardiol 111(2):273-277
17. The urokinase pulmonary embolism trial. A national cooperative study. Circulation. 1973 47(2 Suppl):II1-II108
18. Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL et al (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341(8844):507-511
19. Worster A, Smith C, Silver S, Brown MD (2007) Evidence-based emergency medicine/critically appraised topic. Thrombolytic therapy for submassive pulmonary embolism? Ann Emerg Med 50(1):78-84
20. Tardy B, Venet C, Zeni F, Coudrot M, Guyomarc'h S, Mismetti P (2009) Short term effect of recombinant tissue plasminogen activator in patients with hemodynamically stable acute pulmonary embolism: results of a meta-analysis involving 464 patients. Thromb Res 124(6):672-677
21. Becattini C, Agnelli G, Salvi A, Grifoni S, Pancaldi LG, Enea I et al (2010) Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. Thromb Res 125(3):e82-e86
22. Fasullo S, Scalzo S, Maringhini G, Ganci F, Cannizzaro S, Basile I et al (2011) Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. Am J Med Sci 341(1):33-39
23. Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353(9162):1386-1389 (Pubitemid 29192409)
24. Fiumara K, Kucher N, Fanikos J, Goldhaber SZ (2006) Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol 97(1):127-129 (Pubitemid 41828136)